We demonstrate that factors present in the tumor microenvironment (such as PGE2, VEGF and likely others) activate this ATF3-CH25H regulatory axis to increase the lysosomal activity in the intratumoral DCs leading to degradation and poor cross-presentation of tumor antigens. The gene discussed is VEGFA; the disease is neoplasm.